Hepatic fas antigen expression before and after interferon therapy in patients with chronic hepatitis C
- 1 December 1996
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 41 (12) , 2453-2458
- https://doi.org/10.1007/bf02100142
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Serial assay of hepatitis C virus RNA in serum for predicting response to interferon-α therapyDigestive Diseases and Sciences, 1995
- T cell receptor‐induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin AEuropean Journal of Immunology, 1994
- Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathwaysNature, 1994
- Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis CHepatology, 1994
- Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor familyCell, 1993
- Peripheral-blood mononuclear cell responses to recombinant hepatitis C virus antigens in patients with chronic hepatitis CHepatology, 1993
- DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagementCellular Immunology, 1992
- Suppression of hepatitis C virus RNA by interferon-αThe Lancet, 1990
- Avoiding false positives with PCRNature, 1989
- Treatment of Chronic Non-A, Non-B Hepatitis with Recombinant Human Alpha InterferonNew England Journal of Medicine, 1986